Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

17 November 2026

Anticipating future health risks: Abu Dhabi offers a blueprint for African healthcare

In an article for African Business, Lennox Yieke considers the potential for anticipatory healthcare systems to improve health outcomes in Africa, examining the need to combine investment in digital health and early disease detection with stronger healthcare infrastructure and access to treatment.
Read the full article

SHARE

Reports and publications

The article highlights the persistent barriers that prevent patients living in Africa from obtaining essential medicines, including supply constraints, high prices and limited public financing, particularly in lower-income countries.

Access to Medicine Foundation CEO Jayasree Iyer is quoted emphasising that expanding access to essential medicines requires stronger universal health coverage and public financing. She highlights how the lowest-income African countries often face unfavourable terms or are excluded from agreements with international pharmaceutical companies, and discusses the potential of local and regional manufacturing to strengthen supply security.

She also calls for governments to support local producers through procurement, and for multinational pharmaceutical companies to contribute through licensing, technology transfer and research partnerships. She further highlights voluntary licensing and regulatory harmonisation through the African Medicines Agency as important ways to improve medicine availability and make smaller markets more attractive to manufacturers.

In the media

Read more of our global media coverage
Media

Weight-loss drug boom risks leaving poorer countries behind, study finds

12 November 2026
Media

Access to medicines: innovations not reaching those in need

14 November 2026

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved